The Pathology of MS: New Insights and Potential Clinical Applications

@article{Pittock2007ThePO,
  title={The Pathology of MS: New Insights and Potential Clinical Applications},
  author={Sean J. Pittock and Claudia F. Lucchinetti},
  journal={The Neurologist},
  year={2007},
  volume={13},
  pages={45-56}
}
Background:The pathological hallmarks of the multiple sclerosis (MS) lesion consist of focal demyelination, inflammation, scar formation, and variable axonal destruction. Despite years of classical histopathological study and more recent intensive use of magnetic resonance technology, the MS lesion is incompletely understood. How it is initiated, how it changes over time, how it correlates with clinical symptoms and other markers of disease activity, and how it is impacted by therapeutic… 
Chapter 2 - Differential Diagnosis and Diagnostic Criteria for Multiple Sclerosis: Application and Pitfalls
TLDR
This chapter outlines the development of the current diagnostic criteria for MS and the differentiation of MS from other central nervous system (CNS) inflammatory demyelinating conditions is also addressed.
Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status
TLDR
A distinct combination of CBV and FA characterizes the status of a specific lesion type, and a severe structural impairment does not solely occur in the T1-hypointense lesion, but is also associated with the active lesion.
An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis
TLDR
The chronic EAE mouse model has features that mimic cortical and callosal pathology of MS, and can be potentially used to screen agents to prevent these features of disease.
Clinical Features and Natural History of Multiple Sclerosis
Publisher Summary This chapter focuses on natural history studies, early clini­cal predictors of disability outcome and their application to an individual patient, and the controversy surrounding the
BRAIN VOLUME REDUCTION OVER FOUR DECADES IN MULTIPLE SCLEROSIS
TLDR
Evaluating the atrophy rate (reduction of brain volume and compensatory supratentorial ventricular enlargement) and its correlation to disability and whether atrophy was accelerating or declining over time concluded that the destructive and degenerative effects of MS seem to progress uniformly over long periods of time.
MS: Pathology and Immunology
TLDR
This chapter will review what has been learned from neuropathology, and current concepts on major immunologic disease factors in Multiple Sclerosis, which appears to be heterogeneous, however, with different pathways leading to disease expression.
Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review.
TLDR
The spectrum of available noninvasive techniques, such as electrophysiological and behavioral assessment, optical coherence tomography, scanning laser polarimetry, confocal scanning laser ophthalmoscopy, pupillometry, magnetic resonance imaging, positron emission tomography and cardiovascular monitoring, and their clinical relevance are discussed.
Neurofilament Changes in Multiple Sclerosis
TLDR
This chapter will discuss axonal changes in multiple sclerosis, specifically alterations in neurofilament phosphorylation states, and potential mechanisms of axonal protection.
REVIEW ON MULTIPLE SCLEROSIS
TLDR
In last 20 years it was found that MS is progressive immunological mediated disease of brain and spinal cord (CNS).MS management draws on many disciplines, such as pharmacists, neurologists, speech therapists, nurses, physiotherapists, counselors.
Neuroimaging in Multiple Sclerosis
TLDR
Functional MRI (fMRI), the most recent and advanced nc-MRI technique, has made it possible to investigate mechanisms of cortical neuroplasticity in MS, reporting very promising results.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 127 REFERENCES
Axonal injury in multiple sclerosis
  • K. Rammohan
  • Medicine
    Current neurology and neuroscience reports
  • 2003
TLDR
The finding that irreversible axonal transection occurs in early lesions has underscored now, more than ever before, the need to curtail inflammation and theneed to institute early treatment with disease-modifying agents.
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
TLDR
At a given time point of the disease, the patterns of demyelination were heterogeneous between patients, but were homogenous within multiple active lesions from the same patient, suggesting that MS may be a disease with heterogeneous pathogenetic mechanisms.
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease
TLDR
Most patients undergoing biopsy, who had pathologically confirmed demyelinating disease, were likely to develop MS and remain ambulatory after a median disease duration of 4.4 years, and data suggest that pathogenic implications derived largely from MS biopsy studies may be extrapolated to the general MS population.
Multiple sclerosis: lessons from neuropathology.
TLDR
The spectrum of the inflammatory demyelinating diseases, the multitude of effector mechanisms that may produce myelin destruction, and the pathologic heterogeneity observed in MS lesions are highlighted.
Axonal damage in acute multiple sclerosis lesions.
TLDR
The results show the expression of amyloid precursor protein in damaged axons within acute multiple sclerosis lesions, and in the active borders of less acute lesions, which may have implications for the design and timing of therapeutic intervention.
Axonal injury in multiple sclerosis
  • H. Lassmann
  • Biology, Medicine
    Journal of neurology, neurosurgery, and psychiatry
  • 2003
TLDR
Ferguson et al showed that massive axonal damage occurs during the stage of active demyelination in fresh lesions, and suggested that massive acute axonal injury occurs during a small time window of about two weeks after onset of MS.
Axonal transection in the lesions of multiple sclerosis.
TLDR
Transected axons are common in the lesions of multiple sclerosis, and axonal transection may be the pathologic correlate of the irreversible neurologic impairment in this disease.
Axonal Pathology in Multiple Sclerosis. A Historical Note
Recently, the detection of axonal degeneration in the lesions of multiple sclerosis has attracted new and unexpected attention (24, 57). Magnetic resonance techniques such as MR-spectroscopy (3, 17,
The pathology of multiple sclerosis and its evolution.
  • H. Lassmann
  • Medicine
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 1999
TLDR
It is suggested that the disease process of MS is more complex that previously believed.
Cortical demyelination and diffuse white matter injury in multiple sclerosis.
TLDR
Global brain pathology in multiple sclerosis is analysed, focusing on the normal-appearing white matter (NAWM) and the cortex, to suggest that multiple sclerosis starts as a focal inflammatory disease of the CNS, which gives rise to circumscribed demyelinated plaques in the white matter.
...
1
2
3
4
5
...